Product
HRS-9821
1 clinical trial
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
Safety, Tolerance, Pharmacokinetics and Pharmacodynamics Phase I Study of Increased Doses of Single and Multiple Atomized Inhalation of HRS-9821 Suspension for Inhalation in Healthy PeopleStatus: Recruiting, Estimated PCD: 2023-07-30